Related by context. Frequent words. (Click for all words.) 73 Phase 1b 73 Phase Ib 70 dose escalation study 70 Phase 2b study 69 placebo controlled 65 randomized Phase 65 randomized 65 Phase IIb 65 evaluable patients 64 pivotal Phase 64 Phase 2a 64 sunitinib 64 clinical trial 63 tolerability 63 dosing regimens 63 Phase IIb trial 63 Phase III clinical 63 MGCD# [001] 63 AP# [003] 63 pharmacokinetic 63 mg dose 62 IMGN# 62 pivotal Phase III 62 Phase IIa 62 randomized controlled 62 Phase III 62 randomized placebo controlled 62 dosing 62 Phase 2a clinical 62 DSMB 62 Phase III trials 62 pharmacodynamics 62 randomized double 62 monotherapy 62 Phase 2b 61 CYT# 61 gemcitabine 61 Phase 2b clinical 61 prospective randomized 61 Phase IIb clinical 61 perifosine 61 docetaxel 61 blind randomized placebo 60 randomized clinical 60 double blind placebo 60 antitumor activity 60 rituximab 60 RG# [001] 60 dose regimen 59 T DM1 59 blind randomized 59 non inferiority 59 multicenter 59 bortezomib 59 temozolomide 59 Phase II 59 pharmacokinetics 59 pharmacokinetic profile 59 Phase IIa clinical 59 XL# [003] 59 mg/m2 59 adjuvant therapy 59 pharmacodynamic 59 oral dosing 59 randomization 59 dosing regimen 58 infliximab 58 titration 58 clinical trials 58 carboplatin 58 bevacizumab 58 evaluable 58 randomized clinical trials 58 PRX # 58 FOLOTYN 58 randomized trials 57 chemotherapy regimen 57 blind placebo controlled 57 PMX # 57 ACTEMRA 57 MGCD# [002] 57 carfilzomib 57 nimotuzumab 57 CK # 57 Phase 57 5 FU 57 sorafenib 57 tolerability profile 56 Genasense 56 Phase III clinical trials 56 etanercept 56 cetuximab 56 laquinimod 56 ERBITUX 56 tivozanib 56 daclizumab 56 FTY# 56 pegylated interferon 56 tacrolimus 55 safety tolerability 55 INCB# [002]